
Keywords: دوکسوروبیسین; Hydroxyapatite-targeting; Bisphosphonates; Doxorubicin; Bone tumor; Cardiotoxicity; BBN7-14; HYNIC-βAla-Bombesin7-14; BLI; Bioluminescence Imaging; CHEMS; cholesteryl hemisuccinate; DMEM; Dulbecco's modified Eagle's medium; DOPE; Dioleoylphosphatidyl